461 results on '"Crawford, E. D."'
Search Results
102. Pretreatment of metastatic disease. Prostate cancer in the older male.
103. Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group Study.
104. Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
105. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A Southwest Oncology Group study.
106. Phase II evaluation of suramin in advanced renal cell carcinoma
107. Terazosin, doxazosin, and prazosin: current clinical experience
108. Relationship of demographic and clinical factors to free and total prostate-specific antigen
109. Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)
110. Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review
111. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer
112. Probability of prostate cancer detection based on results of a multicenter study using the AxSYM free PSA and total PSA assays
113. Hypertension in Oregon PesticideFormulating Workers
114. Benign Prostatic Hyperplasia: An Overview
115. The Effect of Ejaculation on Prostate-Specific Antigen in a Prostate Cancer-Screening Population
116. Comparison of Perspectives on Prostate Cancer: Analyses of Survey Data
117. Serum Prostate-Specific Antigen and Digital Rectal Examination for Early Detection of Prostate Cancer in a National Community-Based Program
118. BOOK REVIEWS
119. Intercostal nerve block with thoracoabdominal and flank incisions
120. Comparability of Serum Prostate-Specific Antigen Measurement Between the Hybritech Tandem-R and Abbott AxSYM Assays
121. Introduction to the special section on the ethics of marker tumors in clinical investigation
122. Proposed Substages for Metastatic Prostate Cancer
123. Salvage Radical Prostatectomy After Failed Transperineal Cryotherapy: Histologic Findings from Prostate Whole-Mount Specimens Correlated with Intraoperative Transrectal Ultrasound Images
124. Complications of Cryosurgical Ablation of the Prostate to Treat Localized Adenocarcinoma of the Prostate
125. Computer Simulation of the Probability of Detecting Low Volume Carcinoma of the Prostate With Six Random Systematic Core Biopsies
126. Estimating the Cost Effectiveness of Total Androgen Blockade With Flutamide in M1 Prostate Cancer
127. Evaluation of Age-Specific Normal Ranges for Prostate-Specific Antigen: Editorial Comment
128. An Opportunity to Determine Optimal Treatment of pT3 Prostate Cancer: The Window May Be Closing
129. Screening for Prostate Cancer by Digital Rectal Examination and Prostate-Specific Antigen
130. Hormonal Pretreatment Does Not Affect the Final Pathologic Stage in Locally Advanced Prostate Cancer
131. Effect of Digital Rectal Examination on Monoclonal Hybritech, and Polyclonal Yang Prostatic-Specific Antigen
132. Changing Concepts in the Management of Advanced Prostate Cancer
133. The Use of Strontium 89 for Palliation of Pain from Bone Metastases Associated with Hormone-Refractory Prostate Cancer
134. A Controlled Trial of Bicalutamide Versus Flutamide, Each in Combination with Luteinizing Hormone-Releasing Hormone Analogue Therapy, in Patients with Advanced Prostate Cancer
135. To Pura Belpré White, From E. D. Crawford, The H. W. Wilson Company, 8/26/77.
136. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
137. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
138. Dutasteride: novel milestones in prostate cancer chemoprevention.
139. Radiation therapy after radical prostatectomy.
140. Prostate cancer update.
141. Predictive modeling techniques in prostate cancer.
142. Artificial neural network model to predict biochemical failure after radical prostatectomy.
143. Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis.
144. Use of artificial neural networks in prostate cancer.
145. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study.
146. Clinical staging of prostate cancer: reproducibility and clarification of issues.
147. A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407).
148. Prostate cancer pathology, screening, and epidemiology.
149. Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study.
150. Therapeutic strategies for localized prostate cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.